Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecily Quinn

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancers|February 25, 2023
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its LimitationsBálint Cserni, Darren Kilmartin, Mark O'Loughlin, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2023
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)Constanze Elfgen, Cornelia Leo, Rahel A Kubik-Huch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow CategoriesEmad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2025
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further ManagementEmad A Rakha, Cecily Quinn, Wendy Raymond, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancers|February 25, 2023
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its LimitationsBálint Cserni, Darren Kilmartin, Mark O'Loughlin, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2023
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)Constanze Elfgen, Cornelia Leo, Rahel A Kubik-Huch, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow CategoriesEmad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2025
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further ManagementEmad A Rakha, Cecily Quinn, Wendy Raymond, et al.
The Journal of Pathology|March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practicePaula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Pageof 6